Previous Article | Next Article ![]()
Journal of Clinical Microbiology, November 2001, p. 4142-4144, Vol. 39, No. 11
Max von Pettenkofer-Institut für
Hygiene und Medizinische Mikrobiologie1 and
Dr. v. Haunersches Kinderspital,2 Ludwig
Maximilians-Universität München, 80336 Munich, Germany
Received 23 April 2001/Returned for modification 23 August
2001/Accepted 30 August 2001
Phenotypic susceptibility testing for clarithromycin by E-test and
disk diffusion of 109 cultured Helicobacter pylori isolates was compared with the genotypic susceptibility determination by fluorescent in situ hybridization (FISH). No discrepancies were found
between these three methods. However, FISH has the advantage of
providing results after 3 h.
Clarithromycin is a key component of most
treatment recommendations to eradicate Helicobacter pylori
(1). Resistance of H. pylori to this antibiotic
drug is the most important cause of treatment failure (2, 6,
7). In clinical H. pylori isolates, resistance to
clarithromycin is caused predominantly by three distinct point
mutations within the peptidyl transferase region of the 23S rRNA
(A2143G, A2144G, and A2143C) (8, 10, 14). After culturing
the pathogen from gastric biopsies, probably most laboratories use disk
diffusion or E-test for the determination of macrolide resistance. Both
methods require further subculturing for several days and cannot
identify the type of point mutation present in the strain.
Our laboratory has demonstrated the application of fluorescent in situ
hybridization (FISH) for simultaneous detection of H. pylori
and identification of the 23S rRNA point mutations responsible for
macrolide resistance directly in gastric biopsy specimens (13). In a more recent study, we compared FISH and
conventional culturing for identification of H. pylori in
gastric biopsies (9). The additional application of FISH
to patients' biopsies requires a special preparation (e.g., fixation,
embedding, and sectioning). For laboratories performing conventional
culturing but not FISH directly from biopsy material, it might be an
attractive alternative to use this technique for determination of
clarithromycin resistance in cultured H. pylori strains,
because FISH has the advantage of providing results within hours.
The aim of the present study was to directly compare FISH with E-test
and disk diffusion regarding the practicality and reliability of
clarithromycin susceptibility testing of cultured H. pylori. The pathogen was isolated from antral biopsies obtained from 109 dyspeptic patients with known H. pylori infection. All
oligonucleotide probes used in this study have been previously
described and evaluated (13). Briefly, probe Hpy-1
(5'-CACACCTGACTGACTATCCCG-3') targeted to a 16S rRNA
position was used to specifically identify H. pylori, whereas probes ClaR1 (A2143G) (5'-CGGGGTCTTCCCGTCTT-3'),
ClaR2 (A2144G) (5'-CGGGGTCTCTCCGTCTT-3'), and ClaR3
(A2143C) (5'-CGGGGTCTTGCCGTCTT-3') were designed to detect
23S rRNA point mutations responsible for clarithromycin resistance. In
contrast, probe ClaWT (5'-CGGGGTCTTTCCGTCTT-3') was used to
identify clarithromycin-sensitive H. pylori strains which
had not been detected by either ClaR1, ClaR2, or ClaR3. Oligonucleotide
probes were 5' labeled with the fluorochromes Cy3 (ClaR1, ClaR2, ClaR3,
and ClaWT; red signal) or fluorescein isothiocyanate (Hpy-1; green
signal). This set of hybridization probes is also commercially
available in the creaFAST H. pylori Combi Kit (Oxoid Ltd.,
Basingstoke, United Kingdom). For hybridization of cultured H. pylori, bacteria were suspended in phosphate-buffered saline,
fixed in 4% paraformaldehyde for 30 min at 4°C, subsequently spotted
on five glass slides, and then dried for 15 min at 46°C. Dehydration
steps were carried out in 50, 80, and 96% ethanol for 3 min each.
Glass slides were hybridized with the respective oligonucleotides as
previously described (9). Besides specific labeling with
fluorescent probes, all samples were subsequently stained with DAPI
(4',6'-diamidino-2-phenylindole), which binds to bacterial DNA and thus
helped to localize the microorganisms on glass slides during microscopy
(12, 13).
For clarithromycin susceptibility testing of H. pylori by
disk diffusion and E-test, colonies from agar plates were suspended into a 0.9% NaCl solution and swabbed onto Mueller-Hinton agar plates
supplemented with 5% sheep erythrocytes. After applying 15-µg
clarithromycin disks (Oxoid, Wesel, Germany) or clarithromycin E-test
strips (AB Biodisk, Solna, Sweden) on the agar surface, plates were
incubated in a microaerophilic environment at 37°C for 2 days.
Thereafter, zone diameters and the MIC for each strain were determined.
Each clarithromycin susceptibility testing was repeated twice.
As shown in Table 1, all isolated strains
bound to the H. pylori-specific probe Hpy-1. In 75 of these
109 isolates, binding of probe ClaWT but not of ClaR1, ClaR2, or ClaR3
was observed. In contrast, the remaining 34 isolates hybridized either
with probe ClaR1, ClaR2, or ClaR3, thus identifying the corresponding point mutation responsible for clarithromycin resistance. Twelve strains harbored the point mutation A2143G, 20 strains carried transition A2144G, and only 2 strains with the transversion A2143C were
found. Figure 1 shows typical images
obtained from hybridization of probe ClaR2 with a
clarithromycin-resistant H. pylori isolate harboring the
A2144G point mutation. No cross-reactivity with probes ClaR1, ClaR3, or
ClaWT was observed. By applying FISH to all 109 H. pylori
strains examined in this study, a specific discrimination between
single point mutations causing macrolide resistance and the
corresponding wild-type 23S rRNA associated with clarithromycin sensitivity could be performed.
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.11.4142-4144.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Rapid and Accurate Determination of Genotypic Clarithromycin
Resistance in Cultured Helicobacter pylori by Fluorescent In
Situ Hybridization
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
TABLE 1.
Determination of clarithromycin susceptibility of 109 clinical H. pylori isolates by FISH, disk diffusion, and
E-test

View larger version (15K):
[in a new window]
FIG. 1.
Genotypic detection of H. pylori
clarithromycin resistance by FISH. (Upper panels) Fluorescein
isothiocyanate-labeled oligonucleotide Hpy-1 specifically identifies
H. pylori. Cy3-labeled probe ClaR2 detects the A2144G
transition responsible for macrolide resistance, whereas
oligonucleotides ClaWT/Cy3, ClaR1/Cy3, and ClaR3/Cy3 do not hybridize
to the 23S rRNA of the respective strains. (Lower panels)
Identification of microorganisms on glass slides by staining of
bacterial DNA with DAPI. The microscopic fields correspond to the
respective fields of the upper panel.
As determined by FISH, all 75 clarithromycin-sensitive H. pylori isolates underwent phenotypic testing of susceptibility to the macrolide drug using disk diffusion and E-test. Table 1 demonstrates a complete correlation between all three test methods provided that isolates were considered to be resistant when the MICs of clarithromycin were >2 µg/ml. In the disk diffusion test, all 34 clarithromycin-resistant isolates grew right up to the margin of the disk (Table 1). Apparently, in all 14 strains reactive with oligonucleotide probes ClaR1 or ClaR3, the corresponding point mutations at position 2143 correlated with a high MIC of clarithromycin (>256 µg/ml). In contrast, for 20 H. pylori isolates carrying the point mutation at position 2144, the MICs ranged from 16 µg/ml (4 strains), 24 µg/ml (1 strain), 32 µg/ml (2 strains), 64 µg/ml (2 strains), to >256 µg/ml (11 strains).
Methods for the detection of point mutations in H. pylori at
the molecular level are mainly based on PCR and subsequent restriction length polymorphism or colorimetric hybridization of amplified DNA
fragments (3, 4, 7, 8, 10, 11, 14). Analysis of amplicons
with restriction enzymes BsaI or BbsI
specifically detects the A
G transition at positions 2143 and 2144 but not the A2143C point mutation of the 23 rRNA (7, 14).
In contrast, all three relevant mutations within the peptidyl
transferase region are detectable by the application of a
PCR-oligonucleotide ligation assay (10) or a PCR
hybridization approach (8). In a recent study, a new and
rapid method of detecting A2143G and A2144G point mutations in the 23S
rRNA gene of H. pylori by using a LightCycler has been
reported (5).
The detection of pathogen-specific DNA and genotypic determination of H. pylori macrolide resistance directly in gastric biopsies are useful tools in the microbiology laboratory. Nevertheless, conventional culturing of H. pylori still appears to be mandatory because isolated strains should be used for susceptibility testing with all relevant drugs and for epidemiological studies. Clearly, the disk diffusion test is the most cost-effective and simplest method for the screening of clarithromycin resistance in H. pylori. By applying the more expensive E-test to cultured bacteria, an accurate MIC of the macrolide can be determined. Results from disk diffusion and E-test are available after 2 days of incubation. In contrast, the application of FISH to cultured H. pylori and the microscopic examination of hybridized slides are performed in approximately 3 h and are very easy to carry out. In summary, FISH is a rapid and accurate but also cost-effective method for detection of macrolide resistance in cultured H. pylori, thereby contributing to facilitating the choice of an appropriate treatment regimen for the individual patient.
| |
ACKNOWLEDGMENTS |
|---|
H.R. was supported by the AIDS-Stipendienprogramm from the Bundesministerium für Bildung, Wissenschaft, Forschung und Technologie of Germany.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Max von Pettenkofer-Institut, Ludwig Maximilians-Universität, Pettenkoferstr. 9a, 80336 Munich, Germany. Phone: 0049-89-51605261. Fax: 0049-89-51605223. E-mail: ruessmann{at}m3401.mpk.med.uni-muenchen.de.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
European Helicobacter Pylori Study Group.
1997.
Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report.
Gut
41:8-13 |
| 2. | Graham, D. Y. 1998. Antibiotic resistance in Helicobacter pylori: implications for therapy. Gastroenterology 115:1272-1277[CrossRef][Medline]. |
| 3. |
Maeda, S.,
H. Yoshida,
H. Matsunaga,
K. Ogura,
O. Kawamata,
Y. Shiratori, and M. Omata.
2000.
Detection of clarithromycin-resistant Helicobacter pylori strains by a preferential homoduplex formation assay.
J. Clin. Microbiol.
38:210-214 |
| 4. |
Maeda, S.,
H. Yoshida,
K. Ogura,
F. Kanai,
Y. Shiratori, and M. Omata.
1998.
Helicobacter pylori specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance.
Gut
43:317-321 |
| 5. |
Matsumura, M.,
Y. Hikiba,
K. Ogura,
G. Togo,
I. Tsukuda,
K. Ushikawa,
Y. Shiratori, and M. Omata.
2001.
Rapid detection of mutations in the 23S rRNA gene of Helicobacter pylori that confers resistance to clarithromycin treatment to the bacterium.
J. Clin. Microbiol.
39:691-695 |
| 6. |
Megraud, F.
1998.
Antibiotic resistance in Helicobacter pylori infection.
Br. Med. Bull.
54:207-216 |
| 7. | Occhialini, A., M. Urdaci, F. Doucet-Populaire, C. M. Bebear, H. Lamouliatte, and F. Megraud. 1997. Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes. Antimicrob. Agents Chemother. 41:2724-2728[Abstract]. |
| 8. |
Pina, M.,
A. Occhialini,
L. Monteiro,
H. P. Doermann, and F. Megraud.
1998.
Detection of point mutations associated with resistance of Helicobacter pylori to clarithromycin by hybridization in liquid phase.
J. Clin. Microbiol.
36:3285-3290 |
| 9. |
Rüssmann, H.,
V. A. J. Kempf,
S. Koletzko,
J. Heesemann, and I. B. Autenrieth.
2001.
Comparison of fluorescent in situ hybridization and conventional culturing for detection of Helicobacter pylori in gastric biopsy specimens.
J. Clin. Microbiol.
39:304-308 |
| 10. | Stone, G. G., D. Shortridge, J. Versalovic, J. Beyer, R. K. Flamm, D. Y. Graham, A. T. Ghoneim, and S. K. Tanaka. 1997. A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob. Agents Chemother. 41:712-714[Abstract]. |
| 11. | Szczebara, F., L. Dhaenens, P. Vincent, and M. O. Husson. 1997. Evaluation of rapid molecular methods for detection of clarithromycin resistance in Helicobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 16:162-164[CrossRef][Medline]. |
| 12. |
Trebesius, K.,
D. Harmsen,
A. Rakin,
J. Schmelz, and J. Heesemann.
1998.
Development of rRNA-targeted PCR and in situ hybridization with fluorescently labeled oligonucleotides for detection of Yersinia species.
J. Clin. Microbiol.
36:2557-2564 |
| 13. |
Trebesius, K.,
K. Panthel,
S. Strobel,
K. Vogt,
G. Faller,
T. Kirchner,
M. Kist,
J. Heesemann, and R. Haas.
2000.
Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation.
Gut
46:608-614 |
| 14. | Versalovic, J., D. Shortridge, K. Kibler, M. V. Griffy, J. Beyer, R. K. Flamm, S. K. Tanaka, D. Y. Graham, and M. F. Go. 1996. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 40:477-480[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»